SK29090A3 - £(5-substituted 4-oxo-4h-pyran-2-yl)methyl)chloro-acetates, method of their preparation - Google Patents
£(5-substituted 4-oxo-4h-pyran-2-yl)methyl)chloro-acetates, method of their preparation Download PDFInfo
- Publication number
- SK29090A3 SK29090A3 SK29090A SK29090A SK29090A3 SK 29090 A3 SK29090 A3 SK 29090A3 SK 29090 A SK29090 A SK 29090A SK 29090 A SK29090 A SK 29090A SK 29090 A3 SK29090 A3 SK 29090A3
- Authority
- SK
- Slovakia
- Prior art keywords
- oxo
- preparation
- substituted
- methyl
- pyran
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
íŕ^a aľ 1-ôU· 7YX10- t/*k [(5-$uhiikLCva?w k-c*c--2-y<5) (\ Of^c-Och \d\ jjouj^tcic-^ŕ ^ a-1-ôU · 7YX10- t / * k [(5- $ uhlcLCva ?w k-c * c - 2-y < 5) (Of ^ c-Och jjjj ^ tcic- ^
OhCcijl^ 'ic.díyu tt'y-j ^ Yýiurkcjí. ;x\ Y y'4 ..v £<f5-/íllCMucíVí mjcý) 4 'OxQ-¥i-j^iC\'it·-2-jt )-»U A^· L^Ílk"(’U~Č to J C-1 (X ( C h t- y/C/jiy·OhCciIl ^ iIcIyuItIyIyyIcIycul. y y 4 .. lt ¥ ¥ j j C C C C C C C C C C C C C C C C C C C C C C ^ ^ ^ ^ ^ to J C-1 (X (C h t y / C / yy ·
JcĹL'tOjý ;jklt & H .Λϋίαη t f , 7 'lAUctiηχ! *<-<<'cc.-ui-n.tj '>iu Vč ^ f ulcÍtuiacc . ; .Ide o deriváty 5-hydroxy-2- hydroxymetyl-4-pyronu známeho ako kyselina kojová,ktorá vykazuje antibekteriálnuyantifungálnutprotizápalovú,insekticídmi účinnosť ako 1 kerdiotonickú a kardietoxickú aktivitu· V aúôaetnosti dosiahla najrozličnejšie využitie v kozmetike a i ako larvicíd ovocných a poľnohospodárskych Škodcov· .5?Ccloia(rru ^ *z<-u $--— / I I r / žu cyw ·’·ϊ * > lc [ /5-subs ti tu ovaň, ·' . -4-oxo-4H-pyrán-2-JcĹL'tOj; jklt & H .Λϋίαη t f, 7 'lAUctiηχ! * < - < < 'cc.-ui-n.tj' >; These are 5-hydroxy-2-hydroxymethyl-4-pyrone derivatives known as kojic acid, which exhibit antibacterial antifungal activity by insecticides as a potential and cardietoxic activity. ? Ccloia (rru ^ * from < -u $ --— / II r / zu cyw · '· ϊ * > lc [/ 5-subs ti ova, ·'. -4-oxo-4H-pyran-2 -
Pripravené látky môžu byť medziproduktami pre prípravu látok s biologickou aktivitou·Prepared substances can be intermediates for the preparation of substances with biological activity ·
Spôsob prípravy uvedených létok všeobecného vzorca I spočíva v tomtže na 5-subs ti tuované-2-h.ydroxyme ty 1-4-pyrony sa pôsobí chlóracetylchloridom v bezvodom xyléne pri teplote varu reakčnej zmesi počas reakčnej doby 9 hodín. lsodx^bnooti-f»rí^caay. £ ú JU v l edu-júfrospr i kla de · Μ f f y· · * ÁJicxci^ slíó\í tlcc ti-ťi (< __ 775-fjydro^^4-oxo~4H-py r én-2 -yl/me tyl] chl éra c e t é t 7,0 g /0,05mol/ kyseliny kolovej a 5,65 g /0,05mol/ chlórace-tylchloridu v 100 ml bezvodého xylénu sa zahrieva 9 hodín pod spätným chladičom.Počas zahrievania roztok tmavne a vylučuje sa tuhá látka.Po uplynutí reakčnej doby sa pevná látka odsaje a vákuovo sa oďdestiluje xylén.Do destilačného zvyšku sa pridá 100 ml vody a produkt sa vyextrahuje do chloroformu.The process for the preparation of the above-mentioned drugs of the formula I is based on 5-substituted-2-hydroxymethyl-4-pyrones with chloroacetyl chloride in anhydrous xylene at the reflux temperature of the reaction mixture for 9 hours. lsodx ^ bnooti-f »^ Sri ÇáäÝÓ. In the present invention, there is provided a pharmaceutical composition for use in the production of microcrystalline silicon dioxide (775-dihydro-2,4-oxo-4H-pyridin-2-yl) methyl. 7.0 g / 0.05mol / colloic acid and 5.65g / 0.05mol / chloroacetyl chloride in 100ml of anhydrous xylene are heated under reflux for 9 hours. After the reaction time, the xylene is suctioned off and vacuum-distilled. 100 ml of water are added to the distillation residue and the product is extracted into chloroform.
Po oddestílovaní chloroformu sa spojené pevné podiely prekryš-talizujú z etylacetátu a získa sa 60 % bielej látky^ teplote^c/ topenia 140-141°C.After distilling off the chloroform, the combined solids were recrystallized from ethyl acetate to give 60% of a white solid, m.p. 140-141 ° C.
Analýza pre CgHyO^Cl /M = 218,59/ vypočítané % C = 43,95., % H = 3,23., zistené % C - 44,05., % H = 2,03.Analysis for C 8 H 8 O 2 Cl / M = 218.59 (calculated% C = 43.95,% H = 3.23, found% C - 44.05,% H = 2.03).
Infračervené spektrum /nujol/ v/OH/ = 3150 -3500 cm“1 , = 3068 cm“1 , V1 /0=0/ = 1758,1656 cm“1 , )J/C=C/ = 1624C0T1, 1592 cm“1 , ^/COC/ = 1100-1300 cm“1. UV spektrum /etanol/= 218 nm /log£ = 4,23/., 273 nm /log £=3,90/ 1H-NMR h6 O ° 1 ^[r—- ch2o-c -ch2ciInfrared spectrum (nujol / v / OH) = 3150-3500 cm -1, = 3068 cm -1, V1 / 0 = 0 / = 1758.1656 cm -1, J / C = C / = 1624CT1, 1592 cm -1 1, ^ / COC / = 1100-1300 cm 1. UV spectrum / ethanol = 218 nm / log £ = 4.23 µ, 273 nm / log = = 3.90 / 1 H-NMR 6 0 ° 1 [[r - ch 2 O-c 2 -Cl 2]
o & = 4,16 ppm /CH20/ , 5,01 ppm /CHgCl/ , 6,54 ppm /H3/ , 7,87ppm /H6/. 13c-nmr = 40,30 ppm /CH2C1/ , 62,68 ppm /CH-O/ ,111,67 /C3/ ,137,88 /C / 145,92 /C5/ , 161^54 /000/ ,166,46 /07 ,172,70 /C4/. Týmto spôsobom bol pripravený [/5-metoxy-4-oxo-4Ií-pyI,án-2-yl/ metyl]chlóracetát. Teplota topenia 145“147°C Analýza pre CgH^Cl /M = 232,62/ vypočítané % C = 46,47 , % II =3,90 , zistené % C = 47,50 , % H = 4,10& = 4.16 ppm (CH 2 O), 5.01 ppm (CH 3 Cl 2), 6.54 ppm (H 3), 7.87 ppm (H 6). 13c-nmr = 40.30 ppm (CH 2 Cl 2), 62.68 ppm (CH-O), 111.67 (C 3), 137.88 (C / 145.92 / C5), 161-54 / 000 /, 166 , 46/07, 172.70 (C4). In this way, [5-methoxy-4-oxo-4H-pyridin-2-yl] methyl] chloroacetate was prepared. Melting point: 145 DEG -147 DEG C. Analysis for C9H11Cl2: M = 232.62 (calculated% C = 46.47% II = 3.90, found% C = 47.50,% H = 4.10)
Infračervené spektrum /nujol/ ΤΌΗΑγ/= 3068 cm“1 , ^/0=0/ 1758, 1656 cm"1 , V/C=C/ 1620,1596 cm"1 , *>/000/ 1300-1100. UV spektrum /etanol/ / = 216 nm /log č = 4,16/ , 268nm /log £_Infrared / nujol / ΤΌΗΑγ / = 3068 cm -1, 1/0 = 0/1758, 1656 cm " 1, V / C = C / 1620.1596 cm " 1, * > / 000 / 1300-1100. UV spectrum / ethanol = 216 nm / log n = 4.16, 268 nm / log £.
UluJL = 3,93/UluJL = 3.93 /
Claims (2)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS90290A CS29090A2 (en) | 1990-01-22 | 1990-01-22 | //5-substituted-4-oxo-4h-pyran-2-yl/methyl-chloroacetates and method of their preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
SK277933B6 SK277933B6 (en) | 1995-08-09 |
SK29090A3 true SK29090A3 (en) | 1995-08-09 |
Family
ID=5334759
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK29090A SK29090A3 (en) | 1990-01-22 | 1990-01-22 | £(5-substituted 4-oxo-4h-pyran-2-yl)methyl)chloro-acetates, method of their preparation |
Country Status (2)
Country | Link |
---|---|
CS (1) | CS29090A2 (en) |
SK (1) | SK29090A3 (en) |
-
1990
- 1990-01-22 CS CS90290A patent/CS29090A2/en unknown
- 1990-01-22 SK SK29090A patent/SK29090A3/en unknown
Also Published As
Publication number | Publication date |
---|---|
SK277933B6 (en) | 1995-08-09 |
CS29090A2 (en) | 1991-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU705538B2 (en) | N-substituted dioxothiazolidylbenzamide derivatives and the process for preparing the same | |
Amin et al. | Synthesis and preliminary evaluation of some substituted coumarins as anticonvulsant agents | |
CA2986930C (en) | Chemical modulators of signaling pathways and therapeutic use | |
WO2018030463A1 (en) | Substituted polycyclic pyridone derivative and pharmaceutical composition containing prodrug thereof | |
CN1832939B (en) | Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases | |
Khoshneviszadeh et al. | Design, synthesis and biological evaluation of novel anti-cytokine 1, 2, 4-triazine derivatives | |
EP0547708B1 (en) | Saccharin derivative proteolytic enzyme inhibitors | |
HU227830B1 (en) | 1,2-diphenylpyrrole derivatives, use thereof and pharmaceutical compositions containing the same | |
Doppalapudi et al. | Chemically programmed antibodies: Endothelin receptor targeting CovX-Bodies™ | |
ATE396190T1 (en) | SUBSTITUTED HETEROARYLALKANEOUS ACID AND THEREOF USE AS INHIBITORS OF ALDOSE REDUCTASE | |
JP2008509912A (en) | Heterocyclic compounds as pharmaceuticals | |
PT1206484E (en) | ANTIPICORNAVIRAL COMPOUNDS AND COMPOSITIONS, THEIR PHARMACEUTICAL USES AND MATERIALS FOR THEIR SYNTHESIS | |
Hilgeroth et al. | Synthesis and biological evaluation of first N-alkyl syn dimeric 4-aryl-1, 4-dihydropyridines as competitive HIV-1 protease inhibitors | |
IL144229A (en) | Novel 2-(n-cyanoimino) thiazolidin-4-one derivatives | |
Rodriguez et al. | Synthesis and characterization of tritylthioethanamine derivatives with potent KSP inhibitory activity | |
SK29090A3 (en) | £(5-substituted 4-oxo-4h-pyran-2-yl)methyl)chloro-acetates, method of their preparation | |
Shcherbakov et al. | Modification of polyfluoro-containing 3-(ethoxycarbonyl) flavones by biogenic amines and amino acids | |
CN101070300B (en) | Linonene anologs and its preparing method and use | |
CN102443005A (en) | Spiroheterocycle compound of chalcone and application of spiroheterocycle compound | |
AU2019208634B2 (en) | Dihydroindolizinone derivative | |
Maddi et al. | Synthesis and Antiinflammatory Activity of Substituted (2-oxochromen-3-yl) benzamides. | |
CN108558910B (en) | Schiff base type imidazobenzothiazole compound and preparation method and application thereof | |
CN1318408C (en) | Azo hetercyle beta-elemene derivative and its preparation method and uses | |
Kotoku et al. | Structure‐activity relationships study of bastadin 6, an anti‐angiogenic brominated‐tyrosine derived metabolite from marine sponge | |
Bahgat et al. | Synthesis of new 4-oxo-2-thioxo-1, 2, 3, 4-tetrahydropyrimidine derivatives with an incroporated thiazolidinone moiety and testing their possible serine protease and cercarial elastase inhibitory effects with a possible prospective to block penetration of Schistosoma mansoni cercariae into the mice skin |